Top Story

VIDEO: 'Full spectrum' of melanoma prevention, treatment options available

March 27, 2015

SAN FRANCISCO — In this video, Sancy A Leachman, MD, PhD, discusses the latest developments in the prevention and treatment of melanoma the American Academy of Dermatology Annual Meeting.

“We finally have a full spectrum of prevention, early treatment and late treatment options for melanoma, which is the first time we’ve had this sort of spectrum of possibilities” Leachman, professor and chair of the Department of Dermatology at Oregon Health and Science University and director of the melanoma program at Knight Cancer Institute, told Healio.com/Dermatology.

Dirk Schadendorf, MD In the Journals

Ipilimumab confers long-term survival in advanced melanoma

March 25, 2015
Ipilimumab was associated with long-term OS rates that plateaued after 3 years in patients with unresectable or metastatic melanoma, according to results from a pooled…
Roger M. Perlmutter, MD, PhD Industry News

First-line Keytruda meets co-primary endpoints in advanced melanoma

March 25, 2015
First-line pembrolizumab conferred significant and clinically meaningful improvements in its co-primary endpoints of PFS and OS compared with ipilimumab in a randomized…
Jorge J. Castillo, MD In the Journals

Waldenström’s macroglobulinemia increases risk for secondary malignancies

March 25, 2015
Patients with Waldenström’s macroglobulinemia demonstrated an increased risk for secondary malignancies compared with the general population, according to…
CME
PD-1 Antibodies

PD-1 Antibodies

This activity is supported by educational grants from Bristol-Myers Squibb, Delcath Systems, Inc., Merck & Co., Inc., OncoSec Medical, Inc., Prometheus and Provectus Pharmaceuticals, Inc.

This activity will review data on the efficacy, safety, and response patterns observed with PD-1 in patients with…
More »
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
thumbnail for video 4139087567001 Meeting News CoverageVideo

VIDEO: 'Full spectrum' of melanoma prevention, treatment options available

March 27, 2015
SAN FRANCISCO — In this video, Sancy A Leachman, MD, PhD, discusses the latest developments in the prevention and treatment of melanoma the…
Dirk Schadendorf, MD In the Journals

Ipilimumab confers long-term survival in advanced melanoma

March 25, 2015
Ipilimumab was associated with long-term OS rates that plateaued after 3 years in patients with unresectable or metastatic melanoma, according to…
Roger M. Perlmutter, MD, PhD Industry News

First-line Keytruda meets co-primary endpoints in advanced melanoma

March 25, 2015
First-line pembrolizumab conferred significant and clinically meaningful improvements in its co-primary endpoints of PFS and OS compared with…
Jorge J. Castillo, MD In the Journals

Waldenström’s macroglobulinemia increases risk for secondary malignancies

March 25, 2015
Patients with Waldenström’s macroglobulinemia demonstrated an increased risk for secondary malignancies compared with the general…
thumbnail for video 4126759064001 Meeting News CoverageVideo

Solid organ transplant recipients at higher risk for skin cancer

March 22, 2015
SAN FRANCISCO – In this video, Sarah Tuttleton Arron, MD, PhD, FAAD, discusses her research on mortality from skin cancer after solid organ…
In the Journals

Death from melanoma likely to become 'rare event' in light-skinned populations

March 19, 2015
Death from melanoma over the next several decades should stabilize and then decline in light-skinned populations, according to study results.This…
In the Journals

Study data show increase in use of Mohs' micrographic surgery for skin cancer treatment

March 18, 2015
Researchers observed an increasing trend in the use of Mohs' micrographic surgery to treat skin cancer from 1995 to 2010, particularly in the regions…
In the Journals

Skin cancer biopsy site selfies aided in correct surgical site identification

March 13, 2015
Skin cancer biopsy site selfies taken by patients were shown to be helpful for correct surgical site identification, according to recently published…
In the Journals

Patients with in situ melanoma at higher risk for subsequent melanoma after 2 years

March 12, 2015
Patients whose first cancer was melanoma in situ had a greater risk of developing subsequent melanoma after 2 years following the first diagnosis…
Hensid Tsao In the Journals

AAD task force reviews strengths, weaknesses of ABCDEs of melanoma

March 11, 2015
The American Academy of Dermatology Ad Hoc Task Force for the ABCDEs of Melanoma, chaired by Hensin Tsao, MD, PhD, reviewed the mnemonic for early…
More Headlines »
morganatic-roan